ADAM10 and Alzheimer disease: The findings suggest that in the AD transgenic mice brain, triptolide could not inhibit ADAM10 expression and activity owing to its anti-inflammatory and anti-oxidative effects; however, the molecular mechanisms by which triptolide inhibits APP processing through anti-inflammatory and anti-oxidative pathways in vivo requires additional studies.